ALMSCO International highlights its BenchTOF-dx for improved sensitivity
6 June 2011 | By The Scott Partnership
ALMSCO International, showcasing its state-of-the-art bench-top TOF mass spectrometer, BenchTOF-dx at ASMS 2011...
List view / Grid view
6 June 2011 | By The Scott Partnership
ALMSCO International, showcasing its state-of-the-art bench-top TOF mass spectrometer, BenchTOF-dx at ASMS 2011...
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced new capabilities for laboratories performing a wide range of qualitative and quantitative proteomics workflows.
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
6 June 2011 | By Sanofi
Data will be presented at the ESMO World Congress on Gastrointestinal Cancer...
5 June 2011 | By Merck
Merck commends the GAVI Alliance for their commitment to protecting the lives of children...
5 June 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that PARAMOUNT, met its primary endpoint of progression-free survival...
5 June 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a second Phase 3 randomized, double blind study...
5 June 2011 | By Roche
Roche announced that a Phase III study (BRIM3) showed vemurafenib (RG7204, PLX4032) significantly improved overall survival in people with previously untreated BRAF V600 mutation...
4 June 2011 | By Roche
Roche announced results from OCEANS, a phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy (gemcitabine and carboplatin)...
4 June 2011 | By Johnson & Johnson
This study represents the first randomized, double-blind, placebo controlled Phase III trial to evaluate CTCs as a potential biomarker for overall survival...
4 June 2011 | By GlaxoSmithKline
Results of the PALETTE study presented at the 2011 Annual Meeting of the ASCO...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced fundamentally redefined ion trap mass spectrometer capabilities with the introduction of its new dual-pressure linear ion trap system, the Thermo Scientific Velos Pro.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced a new milestone in Orbitrap technology, the Thermo Scientific Orbitrap Elite.
2 June 2011 | By
Pfizer Inc. and Zhejiang Hisun Pharmaceuticals jointly announced the signing of a MOU on their intention to establish a joint venture...
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Q Exactive high-performance benchtop quadrupole-Orbitrap LC-MS/MS. It is the first commercially available instrument to bring together quadrupole precursor selection and high-resolution accurate mass (HR/AM) Orbitrap mass analysis to deliver high confidence quantitative and qualitative (quan/qual)…